BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 33604618)

  • 21. Knockdown of COPS3 inhibits the progress of prostate cancer through reducing phosphorylated p38 MAPK expression and impairs the epithelial-mesenchymal transition process.
    Zhu Z; Hong Y; Zhang F; An L; Yang Q; Huang X; Xu Q
    Prostate; 2019 Dec; 79(16):1823-1831. PubMed ID: 31509289
    [TBL] [Abstract][Full Text] [Related]  

  • 22. AFF4 facilitates melanoma cell progression by regulating c-Jun activity.
    Hu H; Zhang Y; Zhao L; Zhao W; Wang X; Ye E; Dong Y; Zhang L; Ran F; Zhou Y; Huang Y
    Exp Cell Res; 2021 Feb; 399(2):112445. PubMed ID: 33417923
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Up-regulation of hepatoma-derived growth factor facilitates tumor progression in malignant melanoma [corrected].
    Tsai HE; Wu JC; Kung ML; Liu LF; Kuo LH; Kuo HM; Chen SC; Chan EC; Wu CS; Tai MH; Liu GS
    PLoS One; 2013; 8(3):e59345. PubMed ID: 23536873
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aberrantly enhanced melanoma-associated antigen (MAGE)-A3 expression facilitates cervical cancer cell proliferation and metastasis via actuating Wnt signaling pathway.
    Gao X; Chen G; Cai H; Wang X; Song K; Liu L; Qiu T; He Y
    Biomed Pharmacother; 2020 Feb; 122():109710. PubMed ID: 31918280
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cadherin-12 enhances proliferation in colorectal cancer cells and increases progression by promoting EMT.
    Ma J; Zhao J; Lu J; Wang P; Feng H; Zong Y; Ou B; Zheng M; Lu A
    Tumour Biol; 2016 Jul; 37(7):9077-88. PubMed ID: 26762412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of NCAPG inhibits cardia adenocarcinoma apoptosis and promotes epithelial-mesenchymal transition through the Wnt/β-catenin signaling pathway.
    Zhang X; Zhu M; Wang H; Song Z; Zhan D; Cao W; Han Y; Jia J
    Gene; 2021 Jan; 766():145163. PubMed ID: 32980450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long non-coding RNA GHET1 promotes human breast cancer cell proliferation, invasion and migration via affecting epithelial mesenchymal transition.
    Song R; Zhang J; Huang J; Hai T
    Cancer Biomark; 2018; 22(3):565-573. PubMed ID: 29843220
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GSTO1 regards as a meritorious regulator in cutaneous malignant melanoma cells.
    Wang LK; Yue HL; Peng XJ; Zhang SJ
    Mol Cell Probes; 2019 Dec; 48():101449. PubMed ID: 31525447
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CSN6 promotes melanoma proliferation and metastasis by controlling the UBR5-mediated ubiquitination and degradation of CDK9.
    Zhang Y; Hou J; Shi S; Du J; Liu Y; Huang P; Li Q; Liu L; Hu H; Ji Y; Guo L; Shi Y; Liu Y; Cui H
    Cell Death Dis; 2021 Jan; 12(1):118. PubMed ID: 33483464
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Up-regulated LINC00261 predicts a poor prognosis and promotes a metastasis by EMT process in cholangiocarcinoma.
    Gao J; Qin W; Kang P; Xu Y; Leng K; Li Z; Huang L; Cui Y; Zhong X
    Pathol Res Pract; 2020 Jan; 216(1):152733. PubMed ID: 31812439
    [TBL] [Abstract][Full Text] [Related]  

  • 31. APE1 promotes proliferation and migration of cutaneous squamous cell carcinoma.
    Deng X; Zhen P; Niu X; Dai Y; Wang Y; Zhou M
    J Dermatol Sci; 2020 Oct; 100(1):67-74. PubMed ID: 32951990
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long non-coding RNA SNHG20 predicts a poor prognosis for HCC and promotes cell invasion by regulating the epithelial-to-mesenchymal transition.
    Liu J; Lu C; Xiao M; Jiang F; Qu L; Ni R
    Biomed Pharmacother; 2017 May; 89():857-863. PubMed ID: 28282787
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Knockdown of lncRNA GHET1 inhibits osteosarcoma cells proliferation, invasion, migration and EMT in vitro and in vivo.
    Yang W; Shan Z; Zhou X; Peng L; Zhi C; Chai J; Liu H; Yang J; Zhang Z
    Cancer Biomark; 2018; 23(4):589-601. PubMed ID: 30475755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FARP1 Facilitates Cell Proliferation Through Modulating MAPK Signaling Pathway in Cutaneous Melanoma.
    Chen ZH; Wang LH
    Am J Dermatopathol; 2019 Dec; 41(12):908-913. PubMed ID: 31021836
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of HMGA2 promotes tongue cancer metastasis through EMT pathway.
    Zhao XP; Zhang H; Jiao JY; Tang DX; Wu YL; Pan CB
    J Transl Med; 2016 Jan; 14():26. PubMed ID: 26818837
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma.
    Abudureheman A; Ainiwaer J; Hou Z; Niyaz M; Turghun A; Hasim A; Zhang H; Lu X; Sheyhidin I
    J Cancer Res Clin Oncol; 2018 Jun; 144(6):1025-1035. PubMed ID: 29532228
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RNAi-mediated human Nestin silence inhibits proliferation and migration of malignant melanoma cells by G
    Yang XH; Xia T; Zhang J; Yang SF; Tang HX; Tang T; Huang ZC; Zhong YS; He F; Xiang AP
    J Huazhong Univ Sci Technolog Med Sci; 2017 Dec; 37(6):895-903. PubMed ID: 29270750
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ran GTPase is an independent prognostic marker in malignant melanoma which promotes tumour cell migration and invasion.
    Elsheikh S; Kouzoukakis I; Fielden C; Li W; Lashin SE; Khair N; Raposo TP; Fadhil W; Rudland P; Aleskandarany M; Patel P; El-Tanani M; Ilyas M
    J Clin Pathol; 2022 Jan; 75(1):24-29. PubMed ID: 33234696
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MiR-92b inhibited cells EMT by targeting Gabra3 and predicted prognosis of triple negative breast cancer patients.
    Li YY; Zheng XH; Deng AP; Wang Y; Liu J; Zhou Q; Cheng GY; Jiang Q
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10433-10442. PubMed ID: 31841197
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MiR-363 suppresses cell migration, invasion, and epithelial-mesenchymal transition of osteosarcoma by binding to NOB1.
    Zhang Y; Wang F; Wang L; Zhang Q
    World J Surg Oncol; 2020 May; 18(1):83. PubMed ID: 32357945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.